We are live on
!
Find out more
AI
Alphabet Inc Portfolio holdings
AUM
$4.02B
1-Year Est. Return
215.74%
This Fund
S&P 500
This Quarter
Est. Return
+12.54%
1 Year Est. Return
+215.74%
3 Year Est. Return
+350.01%
5 Year Est. Return
+242.03%
10 Year Est. Return
+998.87%
AUM
$1.72B
AUM Growth
-$125M
(-6.8%)
Cap. Flow
-$234M
Cap. Flow
% of AUM
-13.64%
Top 10 Holdings %
Top 10 Hldgs %
92.89%
Holding
42
New
–
Increased
–
Reduced
2
Closed
2
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GitLab
GTLB
|
+$214M |
| 2 |
Snowflake
SNOW
|
+$13.2M |
| 3 |
Revolution Medicines
RVMD
|
+$6.2M |
| 4 |
RAPT
RAPT Therapeutics
RAPT
|
+$1.09M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 63.06% |
| 2 | Healthcare | 29.23% |
| 3 | Industrials | 7.66% |
| 4 | Consumer Staples | 0.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
GitLab
GTLB
$5.83B
| $343M | 19.98% |
6,091,238
-3,667,095
| -38% | -$214M |
|
2
Freshworks
FRSH
$3.14B
| $262M | 15.26% |
16,206,643
| – | – |
|
3
Arm
ARM
$256B
| $242M | 14.08% |
1,960,784
| – | – |
|
|
4
Revolution Medicines
RVMD
$39.9B
| $181M | 10.53% |
4,133,277
-122,898
| -3% | -$6.2M |
|
5
CrowdStrike
CRWD
$194B
| $146M | 8.52% |
1,711,580
| – | – |
|
6
Planet Labs
PL
$7.3B
| $129M | 7.51% |
31,942,641
| – | – |
|
7
UiPath
PATH
$6.61B
| $89.4M | 5.21% |
7,034,337
| – | – |
|
8
DexCom
DXCM
$31.5B
| $80.6M | 4.69% |
1,036,937
| – | – |
|
|
VERV
9
DELISTED
Verve Therapeutics
VERV
| $69.6M | 4.06% |
12,349,086
| – | – |
|
|
TEM
10
Tempus AI
TEM
$7.92B
| $52.4M | 3.05% |
1,551,102
| – | – |
|
11
Prime Medicine
PRME
$527M
| $44M | 2.56% |
15,062,498
| – | – |
|
12
Vera Therapeutics
VERA
$2.3B
| $10.2M | 0.59% |
241,264
| – | – |
|
13
Monte Rosa Therapeutics
GLUE
$1.4B
| $10.2M | 0.59% |
1,464,015
| – | – |
|
14
Beam Therapeutics
BEAM
$2.63B
| $7.98M | 0.46% |
321,604
| – | – |
|
15
Oscar Health
OSCR
$9.41B
| $6.48M | 0.38% |
481,988
| – | – |
|
16
Relay Therapeutics
RLAY
$4.1B
| $6.46M | 0.38% |
1,568,753
| – | – |
|
17
Sana Biotechnology
SANA
$871M
| $4.58M | 0.27% |
2,812,500
| – | – |
|
18
Dianthus Therapeutics
DNTH
$5.84B
| $4.55M | 0.26% |
208,697
| – | – |
|
19
Lyell Immunopharma
LYEL
$317M
| $3.75M | 0.22% |
293,256
| – | – |
|
20
TScan Therapeutics
TCRX
$48.6M
| $3.27M | 0.19% |
1,077,080
| – | – |
|
|
DM
21
DELISTED
Desktop Metal, Inc.
DM
| $2.59M | 0.15% |
1,104,871
| – | – |
|
22
Foghorn Therapeutics
FHTX
$266M
| $2.36M | 0.14% |
500,901
| – | – |
|
|
BRNS
23
Barinthus Biotherapeutics
BRNS
$22.8M
| $1.83M | 0.11% |
1,513,644
| – | – |
|
24
GeneDx Holdings
WGS
$1.93B
| $1.75M | 0.1% |
22,711
| – | – |
|
|
AUTL
25
Autolus Therapeutics
AUTL
$397M
| $1.64M | 0.1% |
698,262
| – | – |
|
Similar funds
JSW
BWA
MAM
GCM
USCWA
ICP
CA
MGP
Alphabet Inc's Q4 2024 Portfolio in Review
As of Q4 2024, Alphabet Inc held 42 positions worth $1.72B, down 6.8% from $1.84B the previous quarter. Its ten largest holdings account for 93% of the portfolio.
Alphabet Inc withdrew a net $234M in Q4 2024, closing 2 positions and reducing 2 holdings. Its most notable exit was Snowflake, an estimated $13.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 63% of assets, down from 65% a quarter earlier, followed by Healthcare and Industrials.
- Alphabet Inc's biggest Q4 2024 reduction was GitLab, cutting an estimated $214M.
- Alphabet Inc fully exited Snowflake in Q4 2024, selling an estimated $13.2M.
- Alphabet Inc's ten largest holdings make up 93% of its $1.72B portfolio in Q4 2024.
- Alphabet Inc opened 0 new positions and closed 2 in Q4 2024.
- Alphabet Inc's portfolio value fell 6.8% quarter-over-quarter to $1.72B.
Based on Alphabet Inc's 13F filing for Q4 2024, filed 7 Feb 2025.